TP53 and neoplasm: Previous studies have shown that both TP53-WT and point mutant TP53 (R273H/P309S/R248W) can directly suppress ID2 expression, thereby affecting the proliferation capacity of tumor cells [32,33]; our findings indicate that TP53-Q331* exerts the opposite effect by enhancing ID2 expression.